Gadofosveset-enhanced magnetic resonance venography in patients with venous pathology of the lower limbs – Comparison of diagnostic image quality and inter-rater variability with gadobutrol venography and computed tomography venography

Abstract

Purpose

This study was performed to compare the diagnostic quality of Gadofosveset-enhanced magnetic resonance venography with Gadobutrol-enhanced magnetic resonance venography and computed tomography venography for the deep veins of the lower extremities in patients with iliocaval venous pathology.

Materials and methods

Diagnostic capability and image quality were assessed by two independent readers. Inter-reader variability was analyzed by unweighted and quadratic weighted Cohen’s kappa values.

Results

The diagnostic capability was equal to or higher in the Gadofosveset group for all examined vessel segments compared with both control groups. The image quality score was significantly higher for the Gadofosveset group compared to both control groups. Inter-reader variability expressed by quadratic weighted Cohen’s kappa value (k) showed less variability in the Gadofosveset group compared to the control groups.

Conclusion

Our results show that Gadofosveset-enhanced magnetic resonance venography is a reliable technique in clinical routine practice, with image quality superior to both Gadobutrol-enhanced magnetic resonance venography and computed tomography venography.

Keywords

Gadofosveset blood-pool contrast agent magnetic resonance venography imaging deep vein thrombosis

Get full access to this article

View all access options for this article.

References

Kyrle

Eichinger

. Deep vein thrombosis. Lancet 2005; 365: 1163–1174.

Alhadad

Kölbel

Herbst

. Iliocaval vein stenting: long term survey of postthrombotic symptoms and working capacity. J Thromb Thrombolysis 2011; 31: 211–216.

Bækgaard

Klitfod

Broholm

. Safety and efficacy of catheter-directed thrombolysis. Phlebology 2012; 27: 149–154.

Goyen

. Gadofosveset-enhanced magnetic resonance angiography. Vasc Health Risk Manag 2008; 4: 1–9.

Grist

Korosec

Peters

. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998; 207: 539–544.

Bluemke

Stillman

Bis

. Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology 2001; 219: 114–122.

Perreault

Edelman

Baum

. MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial. Radiology 2003; 229: 811–820.

Goyen

Edelman

Perreault

. MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 2005; 236: 825–833.

McGregor

Vymazal

Martinez-Lopez

. A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease. Eur J Radiol 2008; 65: 316–325.

10.

Bonel

Saar

Hoppe

. MR angiography of infrapopliteal arteries in patients with peripheral arterial occlusive disease by using Gadofosveset at 3.0 T: diagnostic accuracy compared with selective DSA. Radiology 2009; 253: 879–890.

11.

Iezzi

Soulez

Thurnher

. Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium. Eur J Radiol 2011; 77: 358–368.

12.

Naehle

Kaestner

Müller

. First-pass and steady-state MR angiography of thoracic vasculature in children and adolescents. JACC Cardiovasc Imaging 2010; 3: 504–513.

13.

Makowski

Wiethoff

Jansen

. Single breath-hold assessment of cardiac function using an accelerated 3D single breath-hold acquisition technique – comparison of an intravascular and extravascular contrast agent. J Cardiovasc Magn Reson 2012; 31: 14–53.

14.

Sharafuddin

Stolpen

Dang

. Comparison of MS-325- and gadodiamide-enhanced MR venography of iliocaval veins. J Vasc Interv Radiol 2002; 13: 1021–1027.

15.

Hansch

Betge

Poehlmann

. Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent. Eur Radiol 2011; 21: 318–325.

16.

Enden

Storås

Negård

. Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA). J Magn Reson Imaging 2010; 31: 416–424.

17.

Partovi

Aschwanden

Staub

. Gadofosveset enhanced MR phlebography for detecting pelvic and deep vein leg thrombosis. Vasa 2011; 40: 315–319.

18.

Pfeil

Betge

Poehlmann

. Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium – an interrater reliability study. Eur J Radiol 2012; 81: 547–552.

19.

Alhadad

Akesson

Lehti

. Safety aspects of gadofosveset in clinical practice – analysis of acute and long-term complications. Magn Reson Imaging 2014; 32: 570–573.

20.

Gaweesh

Kayed

Gaweesh

. Underlying deep venous abnormalities in patients with unilateral chronic venous disease. Phlebology 2013; 28: 426–431.